As of Mar 03
| -0.06 / -1.89%|
The 1 analysts offering 12-month price forecasts for CytRx Corp have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +284.62% increase from the last price of 3.12.
The current consensus among 1 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.